Optimal prevention of seizures induced by high-dose busulfan
about
Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell TransplantationPopulation pharmacokinetics of oral high-dose busulfan in adult patients undergoing hematopoietic stem cell transplantation.Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive diseasSafety of conditioning agents for allogeneic haematopoietic transplantation.Busulfan in hematopoietic stem cell transplant setting.Rheumatologic diseases and posterior reversible encephalopathy syndrome: two case reports and review of the literature.Levetiracetam for the prevention of busulfan-induced seizures in pediatric hematopoietic cell transplantation recipients.The Myeloablative Drug Busulfan Converts Cysteine to Dehydroalanine and Lanthionine in Redoxins.The busulfan metabolite EdAG irreversibly glutathionylates glutaredoxins.Refractory status epilepticus, serious rhabdomyolysis, acute liver injury, and pancytopenia after a massive intake of ethyl methanesulfonate: a case report.Phenytoin-induced reduction of voriconazole serum concentration is not compensated by doubling the dosageClonazepam for seizure prophylaxis in adult patients treated with high dose busulfan.Comparison of levetiracetam with phenytoin for the prevention of intravenous busulfan-induced seizures in hematopoietic cell transplantation recipients
P2860
Q33679931-F243355C-D582-4813-9202-1B59CC9BCBEAQ35596516-4776B39E-0117-4CF6-AFD6-865CA1FEE7A5Q35770722-CA817ECB-7C47-4625-9F1F-D6C1259F0314Q37510948-3D8C7A66-8364-4B50-B010-A0CE32909C56Q37554387-661D199C-F72D-4C26-9132-50A1737928DDQ38028790-3E5B2CF5-23B5-4BC8-BF9D-319EA215A07EQ39747715-6B4C3A3F-EE50-4AAF-A1DF-2E137444BA1AQ42086998-D93286AC-EFA1-49CE-9ECC-97606E21EA42Q42233328-B4006FBB-7C5F-4BA1-A639-BD80E29D7647Q42242861-1420A95F-5E72-4E66-A964-0423BF5244AFQ42590878-78B7EEDD-78D6-44FD-8261-E89F93442CDBQ51251672-3313FE77-9D79-48EA-B758-F7F42D5FA151Q58798385-D9625ACC-BE98-4146-A5BE-CC0B90A481D4
P2860
Optimal prevention of seizures induced by high-dose busulfan
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Optimal prevention of seizures induced by high-dose busulfan
@ast
Optimal prevention of seizures induced by high-dose busulfan
@en
Optimal prevention of seizures induced by high-dose busulfan
@nl
type
label
Optimal prevention of seizures induced by high-dose busulfan
@ast
Optimal prevention of seizures induced by high-dose busulfan
@en
Optimal prevention of seizures induced by high-dose busulfan
@nl
prefLabel
Optimal prevention of seizures induced by high-dose busulfan
@ast
Optimal prevention of seizures induced by high-dose busulfan
@en
Optimal prevention of seizures induced by high-dose busulfan
@nl
P2093
P2860
P356
P1433
P1476
Optimal prevention of seizures induced by high-dose busulfan
@en
P2093
Andrea L Eberly
Gail D Anderson
Jeannine S McCune
Joseph S Bubalo
P2860
P304
P356
10.1592/PHCO.28.12.1502
P407
P577
2008-12-01T00:00:00Z